PMC:7205724 / 113-441 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"3","span":{"begin":139,"end":146},"obj":"Species"},{"id":"5","span":{"begin":218,"end":226},"obj":"Disease"},{"id":"7","span":{"begin":301,"end":309},"obj":"Disease"},{"id":"10","span":{"begin":314,"end":317},"obj":"Gene"}],"attributes":[{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"Tax:9606"},{"id":"A5","pred":"tao:has_database_id","subj":"5","obj":"MESH:C000657245"},{"id":"A7","pred":"tao:has_database_id","subj":"7","obj":"MESH:C000657245"},{"id":"A10","pred":"tao:has_database_id","subj":"10","obj":"Gene:3569"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":": Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of corticosteroids might accelerate recovery from COVID-19.\n• No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":19,"end":34},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":": Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of corticosteroids might accelerate recovery from COVID-19.\n• No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T2","span":{"begin":218,"end":226},"obj":"Disease"},{"id":"T3","span":{"begin":301,"end":309},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":": Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of corticosteroids might accelerate recovery from COVID-19.\n• No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":40,"end":55},"obj":"Chemical"},{"id":"T3","span":{"begin":108,"end":123},"obj":"Chemical"},{"id":"T4","span":{"begin":171,"end":186},"obj":"Chemical"},{"id":"T5","span":{"begin":281,"end":296},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":": Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of corticosteroids might accelerate recovery from COVID-19.\n• No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates"}

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T1","span":{"begin":19,"end":34},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A1","pred":"meddra_id","subj":"T1","obj":"http://purl.bioontology.org/ontology/MEDDRA/10021496"}],"text":": Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of corticosteroids might accelerate recovery from COVID-19.\n• No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T1","span":{"begin":40,"end":55},"obj":"Chemical"},{"id":"T2","span":{"begin":108,"end":123},"obj":"Chemical"},{"id":"T3","span":{"begin":171,"end":186},"obj":"Chemical"},{"id":"T4","span":{"begin":281,"end":296},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":": Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of corticosteroids might accelerate recovery from COVID-19.\n• No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T2","span":{"begin":218,"end":226},"obj":"Species"},{"id":"T3","span":{"begin":301,"end":309},"obj":"Species"}],"attributes":[{"id":"A2","pred":"ncbi_taxonomy_id","subj":"T2","obj":"NCBItxid:2697049"},{"id":"A3","pred":"ncbi_taxonomy_id","subj":"T3","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":": Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of corticosteroids might accelerate recovery from COVID-19.\n• No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T3","span":{"begin":2,"end":55},"obj":"Sentence"},{"id":"T4","span":{"begin":57,"end":67},"obj":"Sentence"},{"id":"T5","span":{"begin":68,"end":156},"obj":"Sentence"},{"id":"T6","span":{"begin":157,"end":227},"obj":"Sentence"},{"id":"T7","span":{"begin":228,"end":310},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":": Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of corticosteroids might accelerate recovery from COVID-19.\n• No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"3","span":{"begin":139,"end":146},"obj":"Species"},{"id":"5","span":{"begin":218,"end":226},"obj":"Disease"},{"id":"7","span":{"begin":301,"end":309},"obj":"Disease"},{"id":"10","span":{"begin":314,"end":317},"obj":"Gene"}],"attributes":[{"id":"A3","pred":"pubann:denotes","subj":"3","obj":"Tax:9606"},{"id":"A5","pred":"pubann:denotes","subj":"5","obj":"MESH:C000657245"},{"id":"A7","pred":"pubann:denotes","subj":"7","obj":"MESH:C000657245"},{"id":"A10","pred":"pubann:denotes","subj":"10","obj":"Gene:3569"}],"text":": Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of corticosteroids might accelerate recovery from COVID-19.\n• No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T1","span":{"begin":314,"end":317},"obj":"Protein"}],"attributes":[{"id":"A1","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q9XT80"},{"id":"A2","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q9UCU4"},{"id":"A3","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q9UCU3"},{"id":"A4","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q9UCU2"},{"id":"A5","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q9MZR1"},{"id":"A6","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q9MYZ7"},{"id":"A7","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q95KN6"},{"id":"A8","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q95181"},{"id":"A9","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q90YI0"},{"id":"A10","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q8MKH0"},{"id":"A11","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q8BN26"},{"id":"A12","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q865X6"},{"id":"A13","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q865W7"},{"id":"A14","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q6V919"},{"id":"A15","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q6L6X6"},{"id":"A16","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q5I6E3"},{"id":"A17","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q3UCQ0"},{"id":"A18","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q2MH06"},{"id":"A19","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q28819"},{"id":"A20","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q28747"},{"id":"A21","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q28319"},{"id":"A22","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q25BC2"},{"id":"A23","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q0PW36"},{"id":"A24","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q0GGL7"},{"id":"A25","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q08DT2"},{"id":"A26","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P79341"},{"id":"A27","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P51494"},{"id":"A28","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P46650"},{"id":"A29","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P41693"},{"id":"A30","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P41683"},{"id":"A31","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P41323"},{"id":"A32","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P29455"},{"id":"A33","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P26893"},{"id":"A34","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P26892"},{"id":"A35","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P20607"},{"id":"A36","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P08505"},{"id":"A37","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/P05231"},{"id":"A38","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/O46568"},{"id":"A39","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/O35736"},{"id":"A40","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/O19007"},{"id":"A41","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/B6CKP4"},{"id":"A42","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/A9QWQ9"},{"id":"A43","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/A3FBE9"},{"id":"A44","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/A0S0B0"}],"text":": Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of corticosteroids might accelerate recovery from COVID-19.\n• No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T16","span":{"begin":0,"end":1},"obj":"-COLON-"},{"id":"T17","span":{"begin":2,"end":17},"obj":"NNS"},{"id":"T18","span":{"begin":17,"end":18},"obj":"-COMMA-"},{"id":"T19","span":{"begin":19,"end":34},"obj":"NNS"},{"id":"T20","span":{"begin":34,"end":35},"obj":"-COMMA-"},{"id":"T21","span":{"begin":36,"end":39},"obj":"CC"},{"id":"T22","span":{"begin":40,"end":55},"obj":"NNS"},{"id":"T23","span":{"begin":57,"end":67},"obj":"NNS"},{"id":"T24","span":{"begin":68,"end":69},"obj":"IN"},{"id":"T25","span":{"begin":71,"end":75},"obj":"NNP"},{"id":"T26","span":{"begin":75,"end":76},"obj":"-COMMA-"},{"id":"T27","span":{"begin":77,"end":85},"obj":"VBN"},{"id":"T28","span":{"begin":86,"end":90},"obj":"IN"},{"id":"T29","span":{"begin":91,"end":104},"obj":"NN"},{"id":"T30","span":{"begin":105,"end":107},"obj":"IN"},{"id":"T31","span":{"begin":108,"end":123},"obj":"NNS"},{"id":"T32","span":{"begin":123,"end":124},"obj":"-COMMA-"},{"id":"T33","span":{"begin":125,"end":130},"obj":"MD"},{"id":"T34","span":{"begin":131,"end":138},"obj":"VB"},{"id":"T35","span":{"begin":139,"end":146},"obj":"NN"},{"id":"T36","span":{"begin":147,"end":155},"obj":"NNS"},{"id":"T37","span":{"begin":157,"end":158},"obj":"PDT"},{"id":"T38","span":{"begin":160,"end":163},"obj":"DT"},{"id":"T39","span":{"begin":164,"end":167},"obj":"NN"},{"id":"T40","span":{"begin":168,"end":170},"obj":"IN"},{"id":"T41","span":{"begin":171,"end":186},"obj":"NNS"},{"id":"T42","span":{"begin":187,"end":192},"obj":"MD"},{"id":"T43","span":{"begin":193,"end":203},"obj":"VB"},{"id":"T44","span":{"begin":204,"end":212},"obj":"NN"},{"id":"T45","span":{"begin":213,"end":217},"obj":"IN"},{"id":"T46","span":{"begin":218,"end":226},"obj":"NN"},{"id":"T47","span":{"begin":228,"end":229},"obj":"PDT"},{"id":"T48","span":{"begin":231,"end":233},"obj":"DT"},{"id":"T49","span":{"begin":234,"end":244},"obj":"VBN"},{"id":"T50","span":{"begin":245,"end":253},"obj":"JJ"},{"id":"T51","span":{"begin":254,"end":260},"obj":"NNS"},{"id":"T52","span":{"begin":261,"end":266},"obj":"VBP"},{"id":"T53","span":{"begin":267,"end":269},"obj":"IN"},{"id":"T54","span":{"begin":270,"end":273},"obj":"DT"},{"id":"T55","span":{"begin":274,"end":277},"obj":"NN"},{"id":"T56","span":{"begin":278,"end":280},"obj":"IN"},{"id":"T57","span":{"begin":281,"end":296},"obj":"NNS"},{"id":"T58","span":{"begin":297,"end":300},"obj":"IN"},{"id":"T59","span":{"begin":301,"end":309},"obj":"NN"},{"id":"T60","span":{"begin":311,"end":312},"obj":"LS"},{"id":"T61","span":{"begin":314,"end":317},"obj":"NN"},{"id":"T62","span":{"begin":318,"end":328},"obj":"VBZ"}],"relations":[{"id":"R15","pred":"arg1Of","subj":"T17","obj":"T18"},{"id":"R16","pred":"arg2Of","subj":"T19","obj":"T18"},{"id":"R17","pred":"arg1Of","subj":"T21","obj":"T20"},{"id":"R18","pred":"arg1Of","subj":"T18","obj":"T21"},{"id":"R19","pred":"arg2Of","subj":"T22","obj":"T21"},{"id":"R20","pred":"arg1Of","subj":"T25","obj":"T24"},{"id":"R21","pred":"arg1Of","subj":"T25","obj":"T26"},{"id":"R22","pred":"arg2Of","subj":"T25","obj":"T27"},{"id":"R23","pred":"arg1Of","subj":"T27","obj":"T28"},{"id":"R24","pred":"arg2Of","subj":"T29","obj":"T28"},{"id":"R25","pred":"arg1Of","subj":"T29","obj":"T30"},{"id":"R26","pred":"arg2Of","subj":"T31","obj":"T30"},{"id":"R27","pred":"arg1Of","subj":"T34","obj":"T32"},{"id":"R28","pred":"arg1Of","subj":"T25","obj":"T33"},{"id":"R29","pred":"arg2Of","subj":"T34","obj":"T33"},{"id":"R30","pred":"arg1Of","subj":"T25","obj":"T34"},{"id":"R31","pred":"arg2Of","subj":"T36","obj":"T34"},{"id":"R32","pred":"arg1Of","subj":"T36","obj":"T35"},{"id":"R33","pred":"arg1Of","subj":"T39","obj":"T37"},{"id":"R34","pred":"arg1Of","subj":"T39","obj":"T38"},{"id":"R35","pred":"arg1Of","subj":"T39","obj":"T40"},{"id":"R36","pred":"arg2Of","subj":"T41","obj":"T40"},{"id":"R37","pred":"arg1Of","subj":"T39","obj":"T42"},{"id":"R38","pred":"arg2Of","subj":"T43","obj":"T42"},{"id":"R39","pred":"arg1Of","subj":"T39","obj":"T43"},{"id":"R40","pred":"arg2Of","subj":"T44","obj":"T43"},{"id":"R41","pred":"arg1Of","subj":"T44","obj":"T45"},{"id":"R42","pred":"arg2Of","subj":"T46","obj":"T45"},{"id":"R43","pred":"arg1Of","subj":"T51","obj":"T47"},{"id":"R44","pred":"arg1Of","subj":"T51","obj":"T48"},{"id":"R45","pred":"arg2Of","subj":"T51","obj":"T49"},{"id":"R46","pred":"arg1Of","subj":"T51","obj":"T50"},{"id":"R47","pred":"arg1Of","subj":"T51","obj":"T52"},{"id":"R48","pred":"arg1Of","subj":"T52","obj":"T53"},{"id":"R49","pred":"arg2Of","subj":"T55","obj":"T53"},{"id":"R50","pred":"arg1Of","subj":"T55","obj":"T54"},{"id":"R51","pred":"arg1Of","subj":"T55","obj":"T56"},{"id":"R52","pred":"arg2Of","subj":"T57","obj":"T56"},{"id":"R53","pred":"arg1Of","subj":"T55","obj":"T58"},{"id":"R54","pred":"arg2Of","subj":"T59","obj":"T58"},{"id":"R55","pred":"arg1Of","subj":"T62","obj":"T60"},{"id":"R56","pred":"arg1Of","subj":"T61","obj":"T62"}],"text":": Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of corticosteroids might accelerate recovery from COVID-19.\n• No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T1","span":{"begin":19,"end":34},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":": Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of corticosteroids might accelerate recovery from COVID-19.\n• No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T2","span":{"begin":218,"end":226},"obj":"Disease"},{"id":"T3","span":{"begin":301,"end":309},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":": Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of corticosteroids might accelerate recovery from COVID-19.\n• No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates"}

{"project":"LitCovid-sentences","denotations":[{"id":"T3","span":{"begin":2,"end":55},"obj":"Sentence"},{"id":"T4","span":{"begin":57,"end":67},"obj":"Sentence"},{"id":"T5","span":{"begin":68,"end":156},"obj":"Sentence"},{"id":"T6","span":{"begin":157,"end":227},"obj":"Sentence"},{"id":"T7","span":{"begin":228,"end":310},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":": Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of corticosteroids might accelerate recovery from COVID-19.\n• No controlled clinical trials exist on the use of corticosteroids for COVID-19.\n• IL6 correlates"}